# JOURNAVX
> **NDA219209** · New Drug Application · Sponsor: VERTEX PHARMS INC · Approved 2025-01-30
## Drug
- **FDA Application Number:** NDA219209
- **Application type:** New Drug Application
- **Brand name:** JOURNAVX
- **Generic name:** SUZETRIGINE
- **Active ingredients:** SUZETRIGINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** VERTEX PHARMS INC
- **Manufacturer:** Vertex Pharmaceuticals Incorporated
- **First approval:** 2025-01-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219209)
---
*AI Analytics · CC0 1.0*